BPMC
Price
$96.62
Change
-$0.00 (-0.00%)
Updated
Nov 12 closing price
92 days until earnings call
DNLI
Price
$29.89
Change
-$0.00 (-0.00%)
Updated
Nov 12 closing price
109 days until earnings call
Ad is loading...

BPMC vs DNLI

Header iconBPMC vs DNLI Comparison
Open Charts BPMC vs DNLIBanner chart's image
Blueprint Medicines
Price$96.62
Change-$0.00 (-0.00%)
Volume$452.58K
CapitalizationN/A
Denali Therapeutics
Price$29.89
Change-$0.00 (-0.00%)
Volume$934.44K
CapitalizationN/A
BPMC vs DNLI Comparison Chart
Loading...
BPMC
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
DNLI
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
BPMC vs. DNLI commentary
Nov 14, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BPMC is a Hold and DNLI is a Buy.

COMPARISON
Comparison
Nov 14, 2024
Stock price -- (BPMC: $96.63 vs. DNLI: $29.64)
Brand notoriety: BPMC and DNLI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BPMC: 68% vs. DNLI: 184%
Market capitalization -- BPMC: $6.15B vs. DNLI: $4.3B
BPMC [@Biotechnology] is valued at $6.15B. DNLI’s [@Biotechnology] market capitalization is $4.3B. The market cap for tickers in the [@Biotechnology] industry ranges from $473.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.83B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BPMC’s FA Score shows that 0 FA rating(s) are green whileDNLI’s FA Score has 0 green FA rating(s).

  • BPMC’s FA Score: 0 green, 5 red.
  • DNLI’s FA Score: 0 green, 5 red.
According to our system of comparison, both BPMC and DNLI are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BPMC’s TA Score shows that 5 TA indicator(s) are bullish while DNLI’s TA Score has 6 bullish TA indicator(s).

  • BPMC’s TA Score: 5 bullish, 5 bearish.
  • DNLI’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, DNLI is a better buy in the short-term than BPMC.

Price Growth

BPMC (@Biotechnology) experienced а -0.94% price change this week, while DNLI (@Biotechnology) price change was +0.30% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.86%. For the same industry, the average monthly price growth was +5.66%, and the average quarterly price growth was +6.44%.

Reported Earning Dates

BPMC is expected to report earnings on Feb 13, 2025.

DNLI is expected to report earnings on Mar 03, 2025.

Industries' Descriptions

@Biotechnology (-1.86% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BPMC($6.15B) has a higher market cap than DNLI($4.3B). DNLI YTD gains are higher at: 38.117 vs. BPMC (4.759). BPMC has higher annual earnings (EBITDA): -75.58M vs. DNLI (-486.71M). DNLI has more cash in the bank: 896M vs. BPMC (734M). DNLI has less debt than BPMC: DNLI (48.8M) vs BPMC (471M). BPMC has higher revenues than DNLI: BPMC (434M) vs DNLI (1.27M).
BPMCDNLIBPMC / DNLI
Capitalization6.15B4.3B143%
EBITDA-75.58M-486.71M16%
Gain YTD4.75938.11712%
P/E RatioN/AN/A-
Revenue434M1.27M34,254%
Total Cash734M896M82%
Total Debt471M48.8M965%
FUNDAMENTALS RATINGS
BPMC vs DNLI: Fundamental Ratings
BPMC
DNLI
OUTLOOK RATING
1..100
1814
VALUATION
overvalued / fair valued / undervalued
1..100
80
Overvalued
94
Overvalued
PROFIT vs RISK RATING
1..100
7678
SMR RATING
1..100
9693
PRICE GROWTH RATING
1..100
4437
P/E GROWTH RATING
1..100
7899
SEASONALITY SCORE
1..100
8575

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BPMC's Valuation (80) in the Biotechnology industry is in the same range as DNLI (94). This means that BPMC’s stock grew similarly to DNLI’s over the last 12 months.

BPMC's Profit vs Risk Rating (76) in the Biotechnology industry is in the same range as DNLI (78). This means that BPMC’s stock grew similarly to DNLI’s over the last 12 months.

DNLI's SMR Rating (93) in the Biotechnology industry is in the same range as BPMC (96). This means that DNLI’s stock grew similarly to BPMC’s over the last 12 months.

DNLI's Price Growth Rating (37) in the Biotechnology industry is in the same range as BPMC (44). This means that DNLI’s stock grew similarly to BPMC’s over the last 12 months.

BPMC's P/E Growth Rating (78) in the Biotechnology industry is in the same range as DNLI (99). This means that BPMC’s stock grew similarly to DNLI’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BPMCDNLI
RSI
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
83%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
74%
Bearish Trend 2 days ago
89%
Momentum
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
78%
MACD
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
74%
Bullish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
79%
Advances
ODDS (%)
Bullish Trend 7 days ago
73%
Bullish Trend 3 days ago
80%
Declines
ODDS (%)
Bearish Trend 2 days ago
73%
Bearish Trend 14 days ago
78%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
76%
Aroon
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
77%
View a ticker or compare two or three
Ad is loading...
BPMC
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
DNLI
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
FOREX / NAMEPrice $Chg $Chg %
CNYHKD1.090.01
+1.38%
China Yuan - Hong Kong Dollar
AUDJPY101.360.38
+0.38%
Australian Dollar - Japan Yen
IBDV21.47N/A
N/A
iShares iBonds Dec 2030 Term Corp ETF
PJFG95.26-0.08
-0.08%
PGIM Jennison Focused Growth ETF
FXU38.74-0.11
-0.28%
First Trust Utilities AlphaDEX® ETF

BPMC and

Correlation & Price change

A.I.dvisor indicates that over the last year, BPMC has been loosely correlated with BBIO. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if BPMC jumps, then BBIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BPMC
1D Price
Change %
BPMC100%
-3.24%
BBIO - BPMC
45%
Loosely correlated
-5.74%
DNLI - BPMC
45%
Loosely correlated
-5.32%
SNDX - BPMC
44%
Loosely correlated
-25.55%
KRYS - BPMC
44%
Loosely correlated
-4.39%
RCKT - BPMC
43%
Loosely correlated
-4.92%
More